Adel Kardosh, MD
Medical Oncology · Portland, ORNPI 1235400177
Payments from drug & device makers
Across 214 payments — averaging $5968.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$584K
- Boehringer Ingelheim$182K
- Seagen Inc.$171K
- Pfizer$119K
- Genentech, Inc.$110K
- Astrazeneca UK Limited$56K
- plus $55K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 68 | $584,126 |
| Boehringer Ingelheim | 7 | $181,706 |
| Seagen Inc. | 88 | $171,267 |
| Pfizer | 3 | $119,170 |
| Genentech, Inc. | 8 | $109,794 |
| Astrazeneca UK Limited | 2 | $56,001 |
| Eisai Inc. | 8 | $16,094 |
| Biontech SE | 2 | $14,331 |
| AstraZeneca | 7 | $10,906 |
| Exelixis Inc. | 7 | $5,222 |
| Jazz Pharmaceuticals Inc. | 1 | $3,296 |
| Genentech USA, Inc. | 4 | $2,939 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $1,638 |
| Boehringer Ingelheim International GmbH | 1 | $299 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Sirtex Medical Inc | 1 | $99 |
| Astellas Pharma US Inc | 1 | $93 |
| Ipsen Biopharmaceuticals, Inc | 1 | $67 |
| F. Hoffmann-la Roche AG | 1 | $61 |
| Janssen Research & Development, LLC | 1 | $38 |
How this compares
$1,277,247 in reported general payments places this provider in the 80th percentile of 92 medical oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Portland
- Matthew TaylorPortland$25.1M
- Rachel SanbornPortland$17.2M
- Christopher RyanPortland$10.3M
- Brendan CurtiPortland$8.6M
- Zahi MitriPortland$8.5M
- Julie GraffPortland$8.5M
- Shivaani KummarPortland$7.8M
- Rom LeidnerPortland$5.5M
- Charles LopezPortland$5.3M
- David PagePortland$4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.